Translational Science Grand Rounds: "The First Clinical Trial Proof for a Strategy to Reduce Dementia Risk: Recent and New Results from SPRINT MIND"

Translational Science Grand Rounds: The First Clinical Trial Proof for a Strategy to Reduce Dementia Risk: Recent and New Results from SPRINT MIND

Presented by: Jeff D. Williamson, MD, MHS (Professor of Internal Medicine and Epidemiology; Chief, Section on Gerontology and Geriatric Medicine; Director, Center for Healthcare Innovation at Wake Forest School of Medicine)

Jeff Williamson is a Professor of Internal Medicine and Epidemiology. He is also Chief, Section on Gerontology and Geriatric Medicine at Wake Forest School of Medicine. He is an internationally known geriatrician and clinical trialist. He is the Director of the Center for Healthcare Innovation, Co-Leader, Alzheimer’s Disease Research Center Administrative Core and Program, Clinical Core PI for the Wake Forest Claude Pepper Older Americans Independence Center and the Wake Forest John A. Hartford Center of Excellence.  He received his MD from the Medical College of Georgia and MHS from Johns Hopkins, where he also completed his fellowship in Geriatric Medicine. His primary research interests are in understanding relationships between chronic diseases and maintaining brain health and physical function in aging adults, the prevention of aging-related loss of independence, and in developing research methods for including elderly persons in clinical trials. His most recent work is in developing and testing approaches to improving care coordination for vulnerable elderly patients as they traverse the health care system. He currently serves on the leadership team for 3 nationwide, NIH-funded studies. Altogether, his NIH studies have involved more than 30,000 adults over age 65 and 15,000 adults over 75.

Monday, September 30, 2019 at 12:00 PM (Lunch will be served at 11:30 AM) in Tidewater Room 1210